Content vaulting is widely hated in Destiny 2, so with Marathon, Bungie wants to make sure its content is "evergreen" and won ...

The "CE" Tactical handgun. Oh they're not even hiding it.

Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.

Real-world community study finds Enhertu in HER2-low metastatic breast cancer has trial-like discontinuation rates; ILD remains key toxicity.

The Tennessee Titans will sign tight end Daniel Bellinger when the league year starts in two days, reuniting him with Brian ...

FDA Priority Review was granted for trastuzumab deruxtecan in post-neoadjuvant HER2-positive early breast cancer with residual invasive disease, with a regulatory decision anticipated in Q3 2026.

Destiny 2 is in trouble, and this is not crying wolf this time as it has lost 98% of its players in the last two years. Can it survive?

MGP Global Partner, an investment management company, released its fourth quarter 2025 investor letter for the "iMGP Small Company Fund”. A copy of the letter can be downloaded here.

FDA grants priority review to T-DXd for high-risk HER2-positive early breast cancer with residual disease, after trial shows markedly better recurrence-free survival than T-DM1.

The second episode premieres on HBO and HBO Max on Sunday, March 8. DTF St. Louis ‘ second episode premieres at 9 p.m. ET on Sundays.

One has to wonder if Saturday's matchup with the Atlanta Hawks is a must-win situation for the Philadelphia 76ers on the road.

Luck running out? The post Why The Future of Bungie’s Marathon Is on Shaky Ground appeared first on ComingSoon.net - Movie Trailers, TV & Streaming News, and More.